← Leaderboards
Elihu Estey
University Of Texas Md Anderson Can Ctr
$3,196,729
Attributed
$3,196,729
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.4M · FY2005–11$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$8,995,651 · 8
By mechanism
P01$8,479,114 · 7
R21$516,537 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- William K Plunkett$8,981,153
- Richard E. Champlin$5,988,814
- Peng Huang$9,110,063
- Ekem T Efuet$680,400
- Stefan Faderl$537,560
Others in their field
Top investigators on “Relative (Related Person)”
- Richard A Gibbs · Baylor College Of Medicine$239,727,270
- Judith S. Currier · University Of California Los Angeles$225,125,900
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$204,659,093
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Daniel R Kuritzkes · Brigham And Women'S Hospital$135,335,138
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$129,832,231
Research focus
Relative (Related Person)ResponseSalvage TherapyChemotherapyPharmaceutical PreparationsBlast CellProgramsNew AgentsAcute Myelogenous LeukemiaDoctor Of MedicineAccountingAra-CClinical TrialsDatabasesPeptide VaccinesMonitorHuman SubjectCytogeneticsLaboratoriesBaseLeadDisease RemissionAmd3100Idarubicin
Grant awards (26)
Clinical Trials in AML$260,715
P01 · FY2011 · CA · contact PI
Clinical Trials in AML$268,780
P01 · FY2010 · CA · contact PI
Clinical Trials in AML$263,310
P01 · FY2009 · CA · contact PI
Evaluating Therapeutic Strategies in MDS$204,487
P01 · FY2009 · CA · contact PI
Administrative Core$136,593
P01 · FY2009 · CA · contact PI
Clinical Trials in AML$260,537
P01 · FY2008 · CA · contact PI
Evaluating Therapeutic Strategies in MDS$148,615
P01 · FY2008 · CA · contact PI
Administrative Core$99,622
P01 · FY2008 · CA · contact PI
New Approaches to the Biology and Treatment of Myelodysplastic Syndromes (MDS)$1,917,919
P01 · FY2007 · CA · contact PI
Clinical Trials in AML$256,802
P01 · FY2007 · CA · contact PI
Evaluating Therapeutic Strategies in MDS$145,347
P01 · FY2007 · CA · contact PI
Administrative Core$97,782
P01 · FY2007 · CA · contact PI
New Approaches to the Biology and Treatment of Myelodysplastic Syndromes (MDS)$1,920,723
P01 · FY2006 · CA · contact PI
Evaluating Therapeutic Strategies in MDS$141,560
P01 · FY2006 · CA · contact PI
Administrative Core$95,381
P01 · FY2006 · CA · contact PI
New Approaches to the Biology and Treatment of Myelodysplastic Syndromes (MDS)$1,960,280
P01 · FY2005 · CA
Evaluating Therapeutic Strategies in MDS$137,437
P01 · FY2005 · CA
Administrative Core$0
P01 · FY2005 · CA
Elimination of Chemotherapy in Newly-Diagnosed APL$252,531
R21 · FY2004 · CA
Elimination of Chemotherapy in Newly-Diagnosed APL$264,006
R21 · FY2003 · CA
CORE--CLINICAL TRIALS IN AML$0
P01 · FY2002 · CA
CORE--AML DATABASE$0
P01 · FY2002 · CA
CHEMOTHERAPY$0
P01 · FY2001 · CA
CORE--AML DATABASE$0
P01 · FY2001 · CA
CORE--CLINICAL TRIALS IN AML$0
P01 · FY2001 · CA
CHEMOTHERAPY$163,224
P01 · FY2000 · CA